FONAR Co. (NASDAQ:FONR – Get Free Report) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 17,100 shares, a growth of 6.2% from the December 15th total of 16,100 shares. Currently, 0.3% of the shares of the company are short sold. Based on an average trading volume of 16,600 shares, the days-to-cover ratio is presently 1.0 days.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded shares of FONAR from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 16th.
View Our Latest Report on FONR
FONAR Price Performance
Institutional Investors Weigh In On FONAR
A number of hedge funds have recently made changes to their positions in FONR. JPMorgan Chase & Co. raised its stake in FONAR by 148.3% during the third quarter. JPMorgan Chase & Co. now owns 3,012 shares of the medical equipment provider’s stock valued at $49,000 after purchasing an additional 1,799 shares in the last quarter. Lakewood Asset Management LLC purchased a new stake in shares of FONAR during the 3rd quarter valued at about $173,000. Empowered Funds LLC lifted its holdings in shares of FONAR by 5.3% in the 3rd quarter. Empowered Funds LLC now owns 18,690 shares of the medical equipment provider’s stock valued at $303,000 after acquiring an additional 938 shares during the last quarter. Corsair Capital Management L.P. grew its position in FONAR by 8.8% in the third quarter. Corsair Capital Management L.P. now owns 27,972 shares of the medical equipment provider’s stock worth $453,000 after acquiring an additional 2,266 shares in the last quarter. Finally, Inspire Advisors LLC increased its stake in FONAR by 21.2% during the third quarter. Inspire Advisors LLC now owns 34,342 shares of the medical equipment provider’s stock worth $556,000 after acquiring an additional 5,998 shares during the last quarter. 50.64% of the stock is currently owned by hedge funds and other institutional investors.
About FONAR
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Read More
- Five stocks we like better than FONAR
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Stock Splits, Do They Really Impact Investors?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What is the FTSE 100 index?
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.